COLLEEN WESLEY: Open Payments
NPI 1992202691 · WESTERVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,389 in 140 payments from 21 companies in 2025. Trend: 2023 $2,250 · 2024 $2,817 · 2025 $3,389
Food & beverage: $3,244Education: $146
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 29 | $870 |
| GENZYME CORPORATION | 16 | $364 |
| ARS Pharmaceuticals Operations, Inc. | 13 | $341 |
| GlaxoSmithKline, LLC. | 16 | $303 |
| CSL Behring | 12 | $215 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $177 |
| Genentech USA, Inc. | 6 | $140 |
| Regeneron Healthcare Solutions, Inc. | 5 | $115 |
| Octapharma USA, Inc. | 5 | $100 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
Products named: DUPIXENT, NEFFY, AIRSUPRA, TEZSPIRE, FASENRA, NUCALA, Xolair, BREZTRI.
Industry payments across OH — which companies pay providers there.
